| Trial name or title | A Study of Cardiovascular Events iN Diabetes (ASCEND) |
| Methods | RCT |
| Participants | Patients with diabetes, without vascular disease |
| Interventions | Each for 7 years: Arm 1: omega‐3 (1 g/d: 0.41 g EPA, 0.34 g DHA) and placebo tablets for aspirin Arm 2: aspirin (100 mg/d) and olive oil placebo capsule Arm 3: omega‐3 (1 g/d) and aspirin (100 mg/d) Arm 4: olive oil placebo and placebo tablets for aspirin |
| Outcomes | Primary: cardiovascular events Secondary: mortality, hospitalisations, cancer |
| Starting date | Registered on trials registry: 24 August 2005 Study start date: March 2005 Estimated study completion date: September 2017 |
| Contact information | Jane Armitage (PI), University of Oxford Clinical Trial Service Unit |
| Notes |
NCT00135226 Trial website: ascend.medsci.ox.ac.uk; rum.ctsu.ox.ac.uk/ascend |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.